Objectives-Bacterial vaginosis (BV) is a prevalent vaginal infection that is now regarded as a risk factor in more serious pelvic and obstetric complications. Spermicides are known to have antimicrobial activity against other sexually transmitted diseases and the aim of this study was to test whether the causative organisms of BV were also susceptible to spermicides, in vitro.
Introduction
The active ingredients of spermicidal preparations are known to have antimicrobial activity in vitro against many of the causative agents of sexually transmitted diseases, including Treponema pallidum, Trichomonas vaginalis, Chlamydia trachomatis, Herpesvirus, types I and II, the Human Immunodeficiency Virus, Mycoplasma hominis, Ureaplasma urealyticum and Haemophilus ducreyi. ' 2 Clinical studies have confirmed that spermicides, particularly when combined with the use of condoms or diaphragms, can also provide effective prophylaxis against these infections in vivo. 3 Bacterial vaginosis (BV) has now become the commonest vaginal infection known4 and, so far, the susceptibility of its causative organisms to spermicide compounds has not been evaluated. This study determined the Minimal Inhibitory Concentration of five spermicidal compounds for Gardnerella vaginalis, Mobiluncus and Bacteroides organisms, in an agar-dilution technique.
Materials and methods Spermicide compounds
The spermicide compounds tested were Nonoxynol-9 (N-9), Nonoxynol-11 (N-1 ), Benzalkonium chloride (BZK), Sodium dodecyl sulpho-succinate (docusate sodium) and c((p-methyl)W-hydroxypoly (Oxyethylene)-(Menfegol). All were supplied by the London International Group, PLC, Cambridge, CB4 4G7, UK.
Culture media
The medium used for culture and maintenance ofthe test strains was Columbia agar base, enriched with defibrinated horse blood, 7.5% and, for MIC determinations, DST agar, enriched with lysed, defibrinated horse blood, 5% (Oxoid Ltd, Basingstoke, RG24 OPW, UK).
Organisms Twenty strains each of G vaginalis, Mobiluncus and Bacteroides organisms were used in the study. All had been isolated from vaginal specimens, taken from patients with BV who had attended the Department of Genitourinary Medicine, the Royal Hallamshire 
Discussion
Vaginal infections affect large numbers of women with a variety of symptoms and sequelae that vary widely in severity. BV is now the most prevalent and rather than merely being the cause of an unpleasant discharge, has become a risk factor in more serious pelvic and obstetric infections. 4 This study has shown the organisms associated with BV to be susceptible to spermicide compounds, in vitro and the concentrations incorporated into contraceptive preparations, usually between 3% and 8%, are far in excess of the MICs found for G vaginalis, Mobiluncus and Bacteroides organisms. These in vitro findings suggest that the use of spermicides could exert a significant antimicrobial effect against BV, in vivo and, together with barrier 
